Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer

Author： McKeage Kate   Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.8, 2008-01, pp. : 699-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab: a guide to its use in early breast cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 12, 2008-12 ,pp. : 4-7

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer

By Plosker Greg L.   Keam Susan J.  

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 449-475

Adis International

Access to resources Recommend Favorite

Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer

By Lamb H.M.   Wiseman L.R.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer

By Dunn Christopher   Keam Susan J.  

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 495-517

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

By Garnock-Jones Karly P.   Keating Gillian M.   Scott Lesley J.  

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 215-239

Adis International

Access to resources Recommend Favorite